Association of platelet aggregation with lipid levels in the Japanese population: The suita study

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 7, 2011, Pages 560-567

  Kameda, Sachika ^a   Sakata, Toshiyuki ^a   Kokubo, Yoshihiro ^a   Mitsuguro, Mana ^a   Okamoto, Akira ^a   Sano, Michitaka ^a   Miyata, Toshiyuki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

LDL cholesterol; Lipid; Platelet aggregation; Platelet count

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; FEMALE; HUMAN; JAPANESE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

ADENOSINE DIPHOSPHATE; ADULT; AGE FACTORS; AGED; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COLLAGEN; FEMALE; HUMANS; JAPAN; LIPIDS; MALE; MIDDLE AGED; PLATELET AGGREGATION;

EID: 79960884525     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.6288     Document Type: Article

References (38)

1. Davi G, Patrono C: Platelet activation and atherothrombosis. N Engl J Med, 2007; 357: 2482-2494
2. O'Donnell CJ, Larson MG, Feng D, Sutherland PA, Lindpaintner K, Myers RH, D'Agostino RA, Levy D, Tofler GH: Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation, 2001; 103: 3051-3056
3. Elwood PC, Beswick A, Pickering J, McCarron P, O'Brien JR, Renaud SR, Flower RJ: Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study. Br J Haematol, 2001; 113: 514-520
4. Fontana P, Dupont A, Gandrille S, Bachelot-Loza C, Reny JL, Aiach M, Gaussem P: Adenosine diphosphateinduced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation, 2003; 108: 989-995
5. Dupont A, Fontana P, Bachelot-Loza C, Reny JL, Bieche I, Desvard F, Aiach M, Gaussem P: An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN. Blood, 2003; 101: 1833-1840
6. Hetherington SL, Singh RK, Lodwick D, Thompson JR, Goodall AH, Samani NJ: Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP. Arterioscler Thromb Vasc Biol, 2005; 25: 252-257
7. Panzer S, Hocker L, Koren D: Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry. Ann Hematol, 2006; 85: 121-125
8. Feng D, Lindpaintner K, Larson MG, O'Donnell CJ, Lipinska I, Sutherland PA, Mittleman M, Muller JE, D'Agostino RB, Levy D, Tofler GH: Platelet glycoprotein a PlA polymorphism, fibrinogen, and platelet aggregability: The Framingham Heart Study. Circulation, 2001; 104: 140-144
9. Yabe M, Matsubara Y, Takahashi S, Ishihara H, Shibano T, Miyaki K, Omae K, Watanabe G, Murata M, Ikeda Y: Identification of ADRA2A polymorphisms related to shear-mediated platelet function. Biochem Biophys Res Commun, 2006; 347: 1001-1005
10. Jones CI, Garner SF, Angenent W, Bernard A, Berzuini C, Burns P, Farndale RW, Hogwood J, Rankin A, Stephens JC, Tom BD, Walton J, Dudbridge F, Ouwehand WH, Goodall AH: Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus. J Thromb Haemost, 2007; 5: 1756-1765
11. Bray PF, Mathias RA, Faraday N, Yanek LR, Fallin MD, Herrera-Galeano JE, Wilson AF, Becker LC, Becker DM: Heritability of platelet function in families with premature coronary artery disease. J Thromb Haemost, 2007; 5: 1617-1623
12. Kunicki TJ, Williams SA, Salomon DR, Harrison P, Crisler P, Nakagawa P, Mondala TS, Head SR, Nugent DJ: Genetics of platelet reactivity in normal, healthy individuals. J Thromb Haemost, 2009; 7: 2116-2122
13. Jones CI, Bray S, Garner SF, Stephens J, de Bono B, Angenent WG, Bentley D, Burns P, Coffey A, Deloukas P, Earthrowl M, Farndale RW, Hoylaerts MF, Koch K, Rankin A, Rice CM, Rogers J, Samani NJ, Steward M, Walker A, Watkins NA, Akkerman JW, Dudbridge F, Goodall AH, Ouwehand WH: A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood, 2009; 114: 1405-1416
14. Johnson M, Ramey E, Ramwell PW: Sex and age differences in human platelet aggregation. Nature, 1975; 253: 355-357
15. Faraday N, Goldschmidt-Clermont PJ, Bray PF: Gender differences in platelet GPb-a activation. Thromb Haemost, 1997; 77: 748-754
16. Becker DM, Segal J, Vaidya D, Yanek LR, Herrera-Galeano JE, Bray PF, Moy TF, Becker LC, Faraday N: Sex differences in platelet reactivity and response to low-dose aspirin therapy. JAMA, 2006; 295: 1420-1427
17. Pernerstorfer T, Stohlawetz P, Stummvoll G, Kapiotis S, Szekeres T, Eichler HG, Jilma B: Low-dose aspirin does not lower in vivo platelet activation in healthy smokers. Br J Haematol, 1998; 102: 1229-1231
18. Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y: Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res, 1999; 93: 271-278
19. Meade TW, Cooper JA, Miller GJ: Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD). Thromb Haemost, 1997; 78: 926-929
20. Mannami T, Baba S, Ogata J: Strong and significant relationships between aggregation of major coronary risk factors and the acceleration of carotid atherosclerosis in the general population of a Japanese city: the Suita Study. Arch Intern Med, 2000; 160: 2297-2303
21. Kokubo Y, Kamide K, Okamura T, Watanabe M, Higashiyama A, Kawanishi K, Okayama A, Kawano Y: Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort: the Suita study. Hypertension, 2008; 52: 652-659
22. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Yoshimasa Y, Okayama A: Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis, 2009; 203: 587-592
23. Mani H, Luxembourg B, Klaffling C, Erbe M, Lindhoff-Last E: Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements. J Clin Pathol, 2005; 58: 747-750
24. Born GV: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature, 1962; 194: 927-929
25. Sakata T, Kario K: Increased plasma plasminogen activator inhibitor-1 levels caused by additional aspirin treatment. Thromb Haemost, 2006; 95: 906-907
26. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
27. Surya II, Akkerman JW: The influence of lipoproteins on blood platelets. Am Heart J, 1993; 125: 272-275
28. Siegel-Axel D, Daub K, Seizer P, Lindemann S, Gawaz M: Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res, 2008; 78: 8-17
29. Mineo C, Deguchi H, Griffin JH, Shaul PW: Endothelial and antithrombotic actions of HDL. Circ Res, 2006; 98: 1352-1364
30. Arai H, Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M: More Intensive Lipid Lowering is Associated with Regression of Coronary Atherosclerosis in Diabetic Patients with Acute Coronary Syndrome. J Atheroscler Thromb, 2010 Jul 28. [Epub ahead of print]
31. Amarenco P, Labreuche J, Touboul PJ: High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis, 2008; 196: 489-496
32. Cui Y, Watson DJ, Girman CJ, Shapiro DR, Gotto AM, Hiserote P, Clearfield MB: Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study). Am J Cardiol, 2009; 104: 829-834
33. Teramoto T, Nakaya N, Yokoyama S, Ohashi Y, Mizuno K, Nakamura H: MEGA Study Group: Association between lowering low-density lipoprotein cholesterol with pravastatin and primary prevention of cardiovascular disease in mild to moderate hypercholesterolemic Japanese. J Atheroscler Thromb, 2010; 17: 879-887
34. Naqvi TZ, Shah PK, Ivey PA, Molloy MD, Thomas AM, Panicker S, Ahmed A, Cercek B, Kaul S: Evidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formation. Am J Cardiol, 1999; 84: 1011-1017
35. Lerch PG, Spycher MO, Doran JE: Reconstituted high density lipoprotein (rHDL) modulates platelet activity in vitro and ex vivo. Thromb Haemost, 1998; 80: 316-320
36. Kastelein JJP, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM, for the TNTaISG: Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment. Circulation, 2008; 117: 3002-3009
37. Trip MD, Cats VM, van Capelle FJ, Vreeken J: Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med, 1990; 322: 1549-1554
38. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF: Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation, 1991; 84: 613-617